Twenty years ago, I pulled up to Sarah's college dorm for our first date, unaware of the magical journey that awaited us.
I am deeply grateful for the wonderful life we have built together. We've navigated life's highs and lows, but nothing compared to the moment of Sarah's bone marrow transplant. I remember the day vividly. As fear and anxiety consumed me in the transplant room, I looked over at Sarah. She beamed with unwavering courage as the bone marrow flowed through the tube and into her body.
Today, as we reflect on that pivotal day, I'm filled with gratitude for the researchers, patients, caregivers, and supporters who made Sarah's transplant possible. Over the years, advancements in multiple myeloma treatment have multiplied, yet the battle against this deadly disease rages on.
That's why I'm participating in the 2024 Defeat Multiple Myeloma Run/Walk on Sunday, June 30. By joining my fundraising efforts, you'll directly contribute to advancing multiple myeloma cancer research at the Fred Hutchinson Cancer Research Center.
Your donation will make a tangible difference, bringing myeloma treatment options to patients faster and funding research toward finding a cure. Together, we're not just running a race – we're building a community, supporting survivors, honoring loved ones lost, and fueling hope for patients.
Please stand with me in this fight. Your support matters more than ever. Together, we can increase our impact and bring us closer to a world without multiple myeloma.
Donate today and let's defeat myeloma together!
What is Multiple Myeloma?
Multiple Myeloma is a cancer of plasma cells found in bone marrow. Normal plasma cells help the immune system fight disease, but when plasma cells become cancerous they grow out of control and can produce a tumor called a plasmacytoma. If someone has more than one plasmacytoma, they have multiple myeloma.
Why support this event?
Defeat Multiple Myeloma’s mission is to raise awareness of multiple myeloma while supporting research that seeks to discover new treatments, improve the quality of life for myeloma patients, and ultimately find a cure for this devastating form of cancer. Funds from the 2024 Defeat Multiple Myeloma event will continue to support immunotherapy research and clinical trials at Fred Hutch which are using CAR-T cells and have shown very promising early results for patients.
